𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Galanin receptors as novel drug targets for the treatment of depression and anxiety

✍ Scribed by Xiaoying Lu; Alasdair M. Barr; Tamas Bartfai

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
151 KB
Volume
65
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

New drug targets for depression and anxi
New drug targets for depression and anxiety: Is the peptides era arriving?
✍ David Gurwitz; Abraham Weizman πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 65 KB

## Abstract The monoamine theory of mood disorders has dominated psychiatric dogma for nearly 50 years. Recent findings about the role of brain peptides in the regulation of emotions and behavior challenge this over‐simplified theory, and are about to open the door for a new era, focused on peptide

Melanin-concentrating hormone receptor 1
Melanin-concentrating hormone receptor 1 antagonists for the treatment of depression and anxiety
✍ Shigeyuki Chaki; Jun-ichi Yamaguchi; Hisaharu Yamada; Kosuke Kanuma; Yoshinori S πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 216 KB πŸ‘ 1 views

## Abstract Melanin‐concentrating hormone (MCH) is a cyclic, 19‐amino‐acid neuropeptide produced in the lateral hypothalamus. MCH is implicated in a number of physiological processes including feeding behavior, energy balance, reproductive function, memory, sleep‐wake regulation, and emotional stat